Publications by authors named "Clara Alcon"

Claim this Profile
Y
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.
Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín, Clara Alcon, Luis Palomero

Pharmaceuticals (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.
Clara Alcon, Marta Kovatcheva, Paula Morales-Sánchez, Vanessa López-Polo, Teresa Torres

Cell Death Differ· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer.
Fernando Martín, Clara Alcon, Elba Marín, Paula Morales-Sánchez, Albert Manzano-Muñoz

Cell Death Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting H3K27 Demethylases Downregulates CREB-CREBBP, Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia.
Juan Lazaro-Navarro, Clara Alcon, Mathurin Dorel, Lina Alasfar, Lorenz Bastian

Cancer Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model.
Aranzazu Villasante, Josep Corominas, Clara Alcon, Andrea Garcia-Lizarribar, Jaume Mora

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.
Vicenç Ruiz de Porras, Adrià Bernat-Peguera, Clara Alcon, Fernando Laguia, Maria Fernández-Saorin

Front Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
Florian Selt, Romain Sigaud, Gintvile Valinciute, Philipp Sievers, Julia Zaman, Clara Alcon

Neuro Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.
Clara Alcon, Fernando Martín, Estela Prada, Jaume Mora, Aroa Soriano

Cell Death Discov· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Line-Specific Network Models of ER Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations.
Jorge Gómez Tejeda Zañudo, Pingping Mao, Clara Alcon, Kailey Kowalski, Gabriela N Johnson

Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia.
Albert Manzano-Muñoz, Clara Alcon, Pablo Menéndez, Manuel Ramírez, Felix Seyfried

Front Cell Dev Biol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
Clara Alcon, Jorge Gómez Tejeda Zañudo, Reka Albert, Nikhil Wagle, Maurizio Scaltriti

Cells· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.
Clara Alcon, Albert Manzano-Muñoz, Estela Prada, Jaume Mora, Aroa Soriano

Cell Death Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New CDK9 Inhibitor on the Block to Treat Hematologic Malignancies.
Clara Alcon, Albert Manzano-Muñoz, Joan Montero

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-Serine dietary supplementation is associated with clinical improvement of loss-of-function -related pediatric encephalopathy.
David Soto, Mireia Olivella, Cristina Grau, Judith Armstrong, Clara Alcon

Sci Signal· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.
David Soto, Mireia Olivella, Cristina Grau, Judith Armstrong, Clara Alcon

Biol Psychiatry· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis